Numerate racks up $5.5M for drug engineering technology
Numerate, a San Bruno, Calif.-based biotech company that streamlines pharmaceutical production pipelines and intellectual property protections, brought in $5.5. million in a second round of funding, according to peHUB. Called the Drug Engineering Process, its system helps research teams set and methodically achieve milestones across different areas, the company says. In its two case studies, it refined therapies for diabetes and HIV.
The funds came from Foundation Capital and Lanza TechVentures. Numerate has bagged $4 million… Continue Reading
Extreme DA, designer of new integratated circuit products, raises $7.38M
Extreme DA, a Palo Alto, Ca designer of integrated circuit products that improve manufacturing yield and handle variations created by the use of nanometer processes in semiconductor production, has raised $7.38 million in a second round of funding.
It was led by Foundation Capital, and included a mix of cash and loans. Other investors included IT-Farm Corporation and Lanza techVentures.
The statement is here.
Here’s a snippet:
“Timing closure is often a challenge for chip designs in smaller process… Continue Reading